4.13Open4.13Pre Close0 Volume186 Open Interest76.00Strike Price0.00Turnover60.44%IV-0.96%PremiumDec 6, 2024Expiry Date4.91Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8940Delta0.0440Gamma15.71Leverage Ratio-0.1414Theta0.0049Rho14.05Eff Leverage0.0126Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet